Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P40
Within normal range
vs 2Y Ago
-13.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-72.29%
202319.67%
20225.32%
2021-130.22%
2020-95.18%
20190.00%